- Home
- ATER vs CVM Comparison
ATER vs CVM Comparison
Compare ATER & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATER
- CVM
- Stock Information
- Founded
- ATER 2014
- CVM 1983
- Country
- ATER United States
- CVM United States
- Employees
- ATER N/A
- CVM N/A
- Industry
- ATER Home Furnishings
- CVM Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ATER Consumer Discretionary
- CVM Health Care
- Exchange
- ATER Nasdaq
- CVM Nasdaq
- Market Cap
- ATER 15.5M
- CVM 18.1M
- IPO Year
- ATER N/A
- CVM 1987
- Fundamental
- Price
- ATER $1.26
- CVM $7.03
- Analyst Decision
- ATER
- CVM
- Analyst Count
- ATER 0
- CVM 0
- Target Price
- ATER N/A
- CVM N/A
- AVG Volume (30 Days)
- ATER 66.5K
- CVM 599.1K
- Earning Date
- ATER 08-13-2025
- CVM 08-18-2025
- Dividend Yield
- ATER N/A
- CVM N/A
- EPS Growth
- ATER N/A
- CVM N/A
- EPS
- ATER N/A
- CVM N/A
- Revenue
- ATER $94,191,000.00
- CVM N/A
- Revenue This Year
- ATER N/A
- CVM N/A
- Revenue Next Year
- ATER $7.48
- CVM N/A
- P/E Ratio
- ATER N/A
- CVM N/A
- Revenue Growth
- ATER N/A
- CVM N/A
- 52 Week Low
- ATER $1.15
- CVM $1.98
- 52 Week High
- ATER $3.84
- CVM $39.30
- Technical
- Relative Strength Index (RSI)
- ATER 43.43
- CVM 53.67
- Support Level
- ATER $1.16
- CVM $8.61
- Resistance Level
- ATER $1.21
- CVM $9.43
- Average True Range (ATR)
- ATER 0.05
- CVM 1.56
- MACD
- ATER 0.00
- CVM -0.13
- Stochastic Oscillator
- ATER 44.00
- CVM 36.17
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development of the treatment of cancer and other diseases using the immune system. The Company's core capabilities include drug discovery, research, development, and manufacturing of complex biological substances. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.